The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial

BACKGROUND: Septic shock remains a significant cause of death in critically ill patients. During septic shock, some patients will retain microcirculatory disorders despite optimal hemodynamic support (i.e., fluid resuscitation, vasopressors, inotropes). Alterations in the microcirculation are a key...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Trials
Päätekijät: Legrand, Matthieu, Oufella, Hafid Ait, De Backer, Daniel, Duranteau, Jacques, Leone, Marc, Levy, Bruno, Rossignol, Patrick, Vicaut, Eric, Dépret, François
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329442/
https://ncbi.nlm.nih.gov/pubmed/32611377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04549-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia